Zigakibart Potently Inhibits A Proliferation-Inducing Ligand-Mediated IgA Production, Addressing IgAN Pathogenesis Root Causes

Introduction: Zigakibart is a humanized IgG4 monoclonal antibody (mAb) binding A proliferation-inducing ligand (APRIL, TNFSF13), a critical factor in IgA nephropathy (IgAN) pathogenesis. Results from the ongoing phase 1/2 ADU-CL-19 study (NCT03945318) have shown clinically meaningful outcomes in pat...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	John Dulos, Joost Kreijtz, Paul Vink, Victoria Cotton, Jay J. Kuo, Jeannette Lo, Wout Jansen, Jeroen Bakker, Lilian Driessen, Marco Guadagnoli, Peter van Zandvoort, Max Warncke, Jan Paul Medema, Jonathan Barratt, Hans van Eenennaam, Andrea Van Elsas
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2026-06-01
Saila:	Kidney International Reports
Gaiak:	antibody APRIL/TNFSF13 IgA nephropathy mode of action plasma cells zigakibart
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2468024926027488
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!